QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 11, 2006

FIVE STAR QUALITY CARE, INC.
(Exact Name of Registrant as Specified in Its Charter)

Maryland (State or other jurisdiction of incorporation)
Commission File No. 1-16817	04-3516029 (IRS Employer Identification No.)
400 Centre Street, Newton, Massachusetts (Address of Principal Executive Offices)	02458 (Zip Code)

Registrant's telephone number, including area code: (617) 796-8387

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

/

/    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

/

/    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

/

/    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

/

/    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.    Other Events.

        This Current Report on Form 8-K/A amends and restates, in its entirety, Item 8.01 of our Current Report on Form 8-K dated October 11, 2006, or the October 2006 8-K, which we filed with the Securities and Exchange Commission to report (i) summary historical and pro forma financial data for the six months ended June 30, 2006, (ii) selected financial data for the years ended December 31, 2003, 2004 and 2005 and for the six months ended June 30, 2005 and 2006, (iii) consolidating subsidiary financial information related to us, our guarantor subsidiaries and our non-guarantor subsidiaries for the years ended December 31, 2003, 2004 and 2005 and for the six months ended June 30, 2005 and 2006 and (iv) unaudited pro forma financial information for the six months ended June 30, 2006. We are amending the consolidating subsidiary financial information related to us, our guarantor subsidiaries and our non-guarantor subsidiaries to reflect certain reclassifications with respect to our guarantor and non-guarantor subsidiaries. All of the other financial information set forth in the October 2006 8-K, as well as Item 9.01 of the October 2006 8-K, remains the same. These reclassifications do not affect our consolidated financial statements.

WARNING CONCERNING FORWARD LOOKING STATEMENTS

THIS CURRENT REPORT ON FORM 8-K/A CONTAINS FORWARD LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND OTHER FEDERAL SECURITIES LAWS, INCLUDING WITH RESPECT TO OUR INTENDED USE OF THE PROCEEDS FROM OUR ISSUANCE OF THE 3.75% CONVERTIBLE SENIOR NOTES DUE 2026. THESE FORWARD LOOKING STATEMENTS ARE BASED UPON OUR PRESENT EXPECTATIONS, BUT THESE STATEMENTS AND THE IMPLICATIONS OF THESE STATEMENTS ARE NOT GUARANTEED.

Summary historical, pro forma and selected financial data of the Company; consolidating subsidiary financial information.

Summary historical and pro forma financial data

        The following summary financial data related to our continuing operations has been derived from our historical financial statements for the six months ended June 30, 2006, and shows, for the period or date presented, our summary historical and our pro forma income statement and balance sheet data, giving effect to (1) our April 2006 offering of 11.5 million of our common shares, or the April 2006 equity offering; (2) the reduction in our management fees payable in respect of 10 Sunrise Senior Living Services, Inc., or SLS, management agreements that we terminated in June 2006; and (3) the October 2006 private placement of $80.0 million of our 3.75% convertible senior notes due 2026, or the convertible senior notes (assuming the initial purchasers over-allotment option is not exercised and not giving effect to conversion of the notes), as if these events had been completed as of the beginning of the period presented. The following data should be read in conjunction with, and is qualified in its entirety by reference to, our historical financial statements incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2005 and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2006 and June 30, 2006 and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" contained therein, and our unaudited pro forma financial statements contained in this Current Report on Form 8-K. Our six month historical financial information contains normal recurring adjustments and is not necessarily indicative of results to be expected in a full year. Comparability of financial results from period to period is affected by acquisitions, closures and our termination of SLS management agreements. Pro forma financial information may not be reflective of what our financial results or financial position would have been had the April 2006 equity offering, the reduction in our management fees payable in respect of 10 SLS management agreements that we terminated in June 2006 and the October 2006

2

private placement of our convertible senior notes been completed as of the dates indicated in our pro forma financial statements. Our pro forma financial information does not give pro forma effect to certain transactions, including, without limitation, the eight senior living communities we began to operate in September and October 2006 and the two rehabilitation hospitals we began to operate in October 2006. You should not place undue reliance on our pro forma financial information.

		For the six months ended June 30, 2006
		Historical			Adjusted for April 2006 equity offering			Adjusted for April 2006 equity offering and 2006 Sunrise terminations			Adjusted for April 2006 equity offering, 2006 Sunrise terminations and convertible senior notes offering
		(amounts in thousands, except per share data)
Statement of Income Data
REVENUES:
	Net revenues from residents	$	365,398		$	365,398		$	365,398		$	365,398
	Pharmacy revenue		24,410			24,410			24,410			24,410
Total revenues			389,808			389,808			389,808			389,808
OPERATING EXPENSES:
Community level operating expenses			281,381			281,381			281,381			281,381
Termination payment to SLS			89,833			89,833			89,833			89,833
Pharmacy expenses			23,189			23,189			23,189			23,189
Management fee to SLS			6,392			6,392			3,059			3,059
Rent expense			52,563			52,563			52,563			52,563
General and administrative			14,635			14,635			14,635			14,635
Depreciation and amortization			4,561			4,561			4,561			4,561
Total operating expenses			472,554			472,554			469,221			469,221
Operating loss			(82,746	)		(82,746	)		(79,413	)		(79,413	)
	Interest and other income		1,140			1,140			1,140			1,140
	Interest expense		(1,633	)		(1,633	)		(1,633	)		(3,294	)(1)
Loss from continuing operations before income taxes			(83,239	)		(83,239	)		(79,906	)		(81,567	)
	Provision for income taxes		—			—			—			—
Loss from continuing operations		$	(83,239	)	$	(83,239	)	$	(79,906	)	$	(81,567	)
Weighted Average Shares Outstanding:
	Basic		25,551			31,581			31,581			31,581
	Fully Diluted		25,551			31,581			31,581			31,581

3

Basic and diluted income per share from continuing operations:
	Basic	$	(3.26	)	$	(2.64	)	$	(2.53	)	$	(2.58	)(2)
	Fully Diluted	$	(3.26	)	$	(2.64	)	$	(2.53	)	$	(2.58	)(2)
EBITDA
Loss from continuing operations		$	(83,239	)	$	(83,239	)	$	(79,906	)	$	(81,567	)
	Add: income taxes		—			—			—			—
	Add: depreciation and amortization		4,561			4,561			4,561			4,561
	Add: interest expense		1,633			1,633			1,633			3,294
	Less: interest and other income		(1,140	)		(1,140	)		(1,140	)		(1,140	)
EBITDA(3)		$	(78,185	)	$	(78,185	)	$	(74,852	)	$	(74,852	)

		As of June 30, 2006
		Actual		Adjusted for convertible senior notes offering
		(dollars in thousands)
Balance Sheet Data
	Cash and cash equivalents	$	23,576	$	101,126
	Total current assets		111,806		189,356
	Total assets		252,334		332,334
	Total current liabilities		83,889		83,889
	Total long term liabilities		71,472		151,472
	Total shareholders' equity	$	96,973	$	96,973

(1)

We have used an assumed interest rate of 4.0% per annum for the convertible senior notes.

(2)

The loss per share includes a loss of $(2.84) per share relating to the termination fees we incurred for the six months ended June 30, 2006 in connection with our termination of 10 SLS management agreements.

(3)

We consider earnings before interest, taxes, depreciation and amortization, or EBITDA, to be an indicative measure of our operating performance. We believe EBITDA is also useful in measuring our ability to service debt, fund capital expenditures and expand our business. Furthermore, we believe that EBITDA is a meaningful disclosure that may help shareholders to understand better our financial performance, including comparing our performance to other companies. However, EBITDA as presented may not be comparable to amounts calculated by other companies. This information should not be considered as an alternative to net income, income from continuing operations, operating profit, cash flow from operations, or any other operating or liquidity performance measure prescribed by accounting principles generally accepted in the United States. Other income excluded from EBITDA consists primarily of amortization of deferred gains.

4

Selected financial data

        The following table presents selected financial data related to our continuing operations which has been derived from our historical financial statements for the years ended December 31, 2003, 2004 and 2005, and for the six months ended June 30, 2005 and 2006, all of which have been adjusted to remove the operations of two skilled nursing home communities in the state of Connecticut that we classified as discontinued operations in June 2006. The following information should be read in connection with, and is qualified in its entirety by reference to, our consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2005 and from our Quarterly Reports on Form 10-Q for the three months ended March 31, 2006 and the six months ended June 30, 2006. The six month information contains normal recurring adjustments and is not necessarily indicative of the results that may be expected in a full year. Additionally, comparability of financial results from period to period is affected by acquisitions, closures and our termination of SLS management agreements. Accordingly, you should not place undue reliance on our historical financial information.

		Year ended December 31,									Six months ended June 30,
		2003			2004			2005			2005			2006
		(amounts in thousands, except per share data)
Revenues:
	Net revenues from residents	$	543,610		$	584,615		$	700,891		$	340,795		$	365,398
	Pharmacy revenue		1,770			13,209			33,476			12,356			24,410
Total revenues			545,380			597,824			734,367			353,151			389,808
Operating expenses:
	Community level operating expenses		434,530			455,755			537,062			260,061			281,381
	Pharmacy expenses		1,666			12,093			32,167			11,451			23,189
	Management fee to SLS		17,272			19,293			21,256			11,240			6,392
	Termination expense for certain SLS management agreements		—			—			86,286			—			89,833
	Rent expense		76,962			82,453			98,890			48,460			52,563
	General and administrative		15,892			18,473			26,559			12,702			14,635
	Depreciation and amortization		3,201			3,371			7,113			3,384			4,561
	Impairment of assets		—			—			2,333			—			—
Total operating expenses			549,523			591,438			811,666			347,298			472,554
Operating (loss) income			(4,143	)		6,386			(77,299	)		5,853			(82,746	)
	Interest and other income		503			1,666			1,543			566			1,140
	Interest expense		(1,439	)		(1,172	)		(3,741	)		(1,860	)		(1,633	)
(Loss) income from continuing operations before income taxes			(5,079	)		6,880			(79,497	)		4,559			(83,239	)
	Provision for income taxes		—			(120	)		—			(73	)		—
(Loss) income from continuing operations		$	(5,079	)	$	6,760		$	(79,497	)	$	4,486		$	(83,239	)
Weighted average shares outstanding			8,482			8,716			14,879			12,219			25,551
Basic and diluted (loss) income per share from:
	Continuing operations	$	(0.60	)	$	0.78		$	(5.34	)	$	0.37		$	(3.26	)
(Loss) income from continuing operations		$	(5,079	)	$	6,760		$	(79,497	)	$	4,486		$	(83,239	)
	Add: income taxes		—			120			—			73			—
	Add: depreciation and amortization		3,201			3,371			7,113			3,384			4,561
	Add: interest expense		1,439			1,172			3,741			1,860			1,633
	Less: interest and other income		(503	)		(1,666	)		(1,543	)		(566	)		(1,140	)
EBITDA		$	(942	)	$	9,757		$	(70,186	)	$	9,237		$	(78,185	)

5

        Consolidating financial information related to the Company, its guarantor subsidiaries and non-guarantor subsidiaries as of June 30, 2006 and 2005 are reflected below.

Unaudited Condensed Consolidating Statement of Operations
For the six months ended June 30, 2006
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		FVE Consolidated
REVENUES:
	Net revenues from residents	$	—		$	163,152		$	202,246		$	—	$	365,398
	Pharmacy revenue		—			—			24,410			—		24,410
Total revenues			—			163,152			226,656			—		389,808
OPERATING EXPENSES:
	Wages and benefits		—			69,435			117,526			—		186,961
	Other operating expenses		—			47,203			47,217			—		94,420
	Termination payment to SLS		—			89,833			—			—		89,833
	Pharmacy expenses		—			—			23,189			—		23,189
	Management fee to SLS		—			6,392			—			—		6,392
	Rent expense		—			32,240			20,323			—		52,563
	General and administrative		—			4,241			10,394			—		14,635
	Depreciation and amortization		—			1,964			2,597			—		4,561
Total operating expenses			—			251,308			221,246			—		472,554
Operating (loss) income			—			(88,156	)		5,410			—		(82,746	)
	Interest and other income		—			142			998			—		1,140
	Interest expense		—			(3	)		(1,630	)		—		(1,633	)
	Equity in earnings of subsidiaries		(85,532	)		—			—			85,532		—
(Loss) income from continuing operations before income taxes			(85,532	)		(88,017	)		4,778			85,532		(83,239	)
	Provision for income taxes		—			—			—			—		—
(Loss) income from continuing operations			(85,532	)		(88,017	)		4,778			85,532		(83,239	)
Loss from discontinued operations			—			(94	)		(2,199	)		—		(2,293	)
Net (loss) income		$	(85,532	)	$	(88,111	)	$	2,579		$	85,532	$	(85,532	)

6

Unaudited Condensed Consolidating Statement of Operations
For the six months ended June 30, 2005
(amounts in thousands)

		Parent		Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
REVENUES:
	Net revenues from residents	$	—	$	156,454		$	184,341		$	—		$	340,795
	Pharmacy revenue		—		—			12,356			—			12,356
Total revenues			—		156,454			196,697			—			353,151
OPERATING EXPENSES:
	Wages and benefits		—		65,697			108,629			—			174,326
	Other operating expenses		—		42,815			42,920			—			85,735
	Pharmacy expenses		—		—			11,451			—			11,451
	Management fee to SLS		—		11,240			—			—			11,240
	Rent expense		—		32,201			16,259			—			48,460
	General and administrative		—		—			12,702			—			12,702
	Depreciation and amortization		—		1,246			2,138			—			3,384
Total operating expenses			—		153,199			194,099			—			347,298
Operating income			—		3,255			2,598			—			5,853
	Interest and other income		—		114			452			—			566
	Interest expense		—		—			(1,860	)		—			(1,860	)
	Equity in earnings of subsidiaries		2,420		—			—			(2,420	)		—
Income (loss) from continuing operations before income taxes			2,420		3,369			1,190			(2,420	)		4,559
	Provision for income taxes		—		—			(73	)		—			(73	)
Income (loss) from continuing operations			2,420		3,369			1,117			(2,420	)		4,486
Loss from discontinued operations			—		(71	)		(1,995	)		—			(2,066	)
Net income (loss)		$	2,420	$	3,298		$	(878	)	$	(2,420	)	$	2,420

7

Unaudited Condensed Consolidating Balance Sheet
As of June 30, 2006
(amounts in thousands)

	Parent		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			FVE Consolidated
ASSETS
Current Assets
Cash	$	—	$	2,499	$	21,077	$	—		$	23,576
Accounts receivable, net		—		13,892		32,448		—			46,340
Prepaid expenses and other current assets		—		3,309		38,581		—			41,890
Total current assets		—		19,700		92,106		—			111,806
Property and equipment, net		—		19,820		82,230		—			102,050
Investment in subsidiary and long term recievable from (to) subsidiaries		200		—		200		(400	)		—
Restricted cash		—		—		13,697		—			13,697
Intercompany		227,808		—		—		(227,808	)		—
Mortgage notes receivable		—		—		3,725		—			3,725
Goodwill		—		—		16,901		—			16,901
Other long term assets		—		402		3,753		—			4,155
Total assets	$	228,008	$	39,922	$	212,612	$	(228,208	)	$	252,334
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Accounts payable and other current liabilities	$	—	$	27,898	$	55,365	$	—		$	83,263
Current mortgage notes payable		—		—		626		—			626
Total current liabilities		—		27,898		55,991		—			83,889
Long term liabilities:
Mortgage notes payable		—		—		44,423		—			44,423
Notes payable to related parties		200		—		—		(200	)		—
Other long term liabilities		—		7,128		19,921		—			27,049
Total long term liabilities		200		7,128		64,344		(200	)		71,472
Total shareholders' equity		227,808		4,896		92,277		(228,008	)		96,973
Total liabilities and shareholders' equity	$	228,008	$	39,922	$	212,612	$	(228,208	)	$	252,334

8

Unaudited Condensed Consolidating Balance Sheet
As of June 30, 2005
(amounts in thousands)

	Parent		Guarantor Subsidiaries		Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
ASSETS
Current Assets
Cash	$	—	$	12,698	$	6,006		$	—		$	18,704
Accounts receivable, net		—		11,937		27,315			—			39,252
Prepaid expenses and other current assets		—		10,395		16,309			—			26,704
Total current assets		—		35,030		49,630			—			84,660
Property and equipment, net		—		13,858		133,303			—			147,161
Investment in subsidiary and long term recievable from (to) subsidiaries		200		—		200			(400	)		—
Restricted cash		—		—		16,631			—			16,631
Intercompany		56,654		—		—			(56,654	)		—
Mortgage notes receivable		—		—		6,036			—			6,036
Goodwill		—		—		16,746			—			16,746
Other long term assets		—		402		(402	)		—			—
Total assets	$	56,854	$	49,290	$	222,144		$	(57,054	)	$	271,234
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Accounts payable and other current liabilities	$	—	$	32,403	$	41,015		$	—		$	73,418
Current mortgage notes payable		—		—		6,051			—			6,051
Total current liabilities		—		32,403		47,066			—			79,469
Long term liabilities:
Mortgage notes payable		—		—		69,056			—			69,056
Notes payable to related parties		200		—		—			(200	)		—
Other long term liabilities		—		6,770		17,345			—			24,115
Total long term liabilities		200		6,770		86,401			(200	)		93,171
Total shareholders' equity		56,654		10,117		88,677			(56,854	)		98,594
Total liabilities and shareholders' equity	$	56,854	$	49,290	$	222,144		$	(57,054	)	$	271,234

9

Unaudited Condensed Consolidating Cash Flow Statement
For the six months ended June 30, 2006
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
Cash Flows from operating activities:
Net (loss) income		$	(85,532	)	$	(88,111	)	$	2,579		$	85,532		$	(85,532	)
Undistributed equity in earnings of subsidiaries			85,532			—			—			(85,532	)		—
Adjustments to reconcile net (loss) income to cash provided by (used in) operating activities, net			—			84,949			(91,142	)		—			(6,193	)
	Net cash used in operating activities		—			(3,162	)		(88,563	)		—			(91,725	)
Cash Flows from investing activities:
Capital expenditures			—			(8,323	)		(15,263	)		—			(23,586	)
Proceeds from the sale of property and equipment			—			5,746			5,331			—			11,077
Other, net			—			1,012			(3,710	)		—			(2,698	)
	Net cash used in investing activities		—			(1,565	)		(13,642	)		—			(15,207	)
Cash Flows from financing activities:
Proceeds from issuance of common shares, net			—			—			114,059			—			114,059
Change in borrowings, net			—			—			(280	)		—			(280	)
Other, net			—			—			—			—			—
	Net cash provided by financing activities		—			—			113,779			—			113,779
Change in cash and cash equivalents			—			(4,727	)		11,574			—			6,847
Cash and cash equivalents at beginning of period			—			7,226			9,503			—			16,729
Cash and cash equivalents at end of period		$	—		$	2,499		$	21,077		$	—		$	23,576

10

Unaudited Condensed Consolidating Cash Flow Statement
For the six months ended June 30, 2005
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
Cash Flows from operating activities:
Net income (loss)		$	2,420		$	3,298		$	(878	)	$	(2,420	)	$	2,420
Undistributed equity in earnings of subsidiaries			(2,420	)		—			—			2,420			—
Adjustments to reconcile net income (loss) to cash provided by operating activities, net			—			3,666			12,687			—			16,353
	Net cash provided by operating activities		—			6,964			11,809			—			18,773
Cash Flows from investing activities:
Capital expenditures			—			(7,012	)		(79,802	)		—			(86,814	)
Proceeds from the sale of property and equipment			—			3,988			25,574			—			29,562
Other, net			—			371			(6,656	)		—			(6,285	)
	Net cash used in investing activities		—			(2,653	)		(60,884	)		—			(63,537	)
Cash Flows from financing activities:
Proceeds from issuance of common shares, net			—			—			—			—			—
Change in borrowings, net			—			—			32,526			—			32,526
Other, net			—			—			—			—			—
	Net cash provided by financing activities		—			—			32,526			—			32,526
Change in cash and cash equivalents			—			4,311			(16,549	)		—			(12,238	)
Cash and cash equivalents at beginning of period			—			8,387			22,555			—			30,942
Cash and cash equivalents at end of period		$	—		$	12,698		$	6,006		$	—		$	18,704

11

        Consolidating financial information related to the Company, its guarantor subsidiaries and non-guarantor subsidiaries as of December 31, 2005, 2004 and 2003 are reflected below.

Unaudited Condensed Consolidating Statement of Operations
For the year ended December 31, 2005
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		FVE Consolidated
REVENUES:
	Net revenues from residents	$	—		$	314,764		$	386,127		$	—	$	700,891
	Pharmacy revenue		—			—			33,476			—		33,476
Total revenues			—			314,764			419,603			—		734,367
OPERATING EXPENSES:
	Wages and benefits		—			133,150			223,217			—		356,367
	Other operating expenses		—			90,382			90,313			—		180,695
	Termination payment to SLS		—			86,286			—			—		86,286
	Pharmacy expenses		—			—			32,167			—		32,167
	Management fee to SLS		—			21,256			—			—		21,256
	Rent expense		—			64,556			34,334			—		98,890
	General and administrative		—			—			26,559			—		26,559
	Depreciation and amortization		—			2,552			4,561			—		7,113
	Impairment of assets		—			—			2,333			—		2,333
Total operating expenses			—			398,182			413,484			—		811,666
Operating (loss) income			—			(83,418	)		6,119			—		(77,299	)
	Interest and other income		—			308			1,235			—		1,543
	Interest expense		—			—			(3,741	)		—		(3,741	)
	Equity in earnings of subsidiaries		(84,159	)		—			—			84,159		—
(Loss) income from continuing operations before income taxes			(84,159	)		(83,110	)		3,613			84,159		(79,497	)
	Provision for income taxes		—			—			—			—		—
(Loss) income from continuing operations			(84,159	)		(83,110	)		3,613			84,159		(79,497	)
Loss from discontinued operations			—			(272	)		(4,390	)		—		(4,662	)
Net (loss) income		$	(84,159	)	$	(83,382	)	$	(777	)	$	84,159	$	(84,159	)

12

Unaudited Condensed Consolidating Statement of Operations
For the year ended December 31, 2004
(amounts in thousands)

		Parent		Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
REVENUES:
	Net revenues from residents	$	—	$	301,550		$	283,065		$	—		$	584,615
	Pharmacy revenue		—		—			13,209			—			13,209
Total revenues			—		301,550			296,274			—			597,824
OPERATING EXPENSES:
	Wages and benefits		—		126,868			175,414			—			302,282
	Other operating expenses		—		88,338			65,135			—			153,473
	Pharmacy expenses		—		—			12,093			—			12,093
	Management fee to SLS		—		19,293			—			—			19,293
	Rent expense		—		64,023			18,430			—			82,453
	General and administrative		—		—			18,473			—			18,473
	Depreciation and amortization		—		1,245			2,126			—			3,371
Total operating expenses			—		299,767			291,671			—			591,438
Operating income			—		1,783			4,603			—			6,386
	Interest and other income		—		110			1,556			—			1,666
	Interest expense		—		—			(1,172	)		—			(1,172	)
	Equity in earnings of subsidiaries		3,291		—			—			(3,291	)		—
Income (loss) from continuing operations before income taxes			3,291		1,893			4,987			(3,291	)		6,880
	Provision for income taxes		—		—			(120	)		—			(120	)
Income (loss) from continuing operations			3,291		1,893			4,867			(3,291	)		6,760
Loss from discontinued operations			—		(692	)		(2,777	)		—			(3,469	)
Net income (loss)		$	3,291	$	1,201		$	2,090		$	(3,291	)	$	3,291

13

Unaudited Condensed Consolidating Statement of Operations
For the year ended December 31, 2003
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		FVE Consolidated
REVENUES:
	Net revenues from residents	$	—		$	292,165		$	251,445		$	—	$	543,610
	Pharmacy revenue		—			—			1,770			—		1,770
Total revenues			—			292,165			253,215			—		545,380
OPERATING EXPENSES:
	Wages and benefits		—			126,177			165,457			—		291,634
	Other operating expenses		—			86,464			56,432			—		142,896
	Pharmacy expenses		—			—			1,666			—		1,666
	Management fee to SLS		—			17,272			—			—		17,272
	Rent expense		—			63,728			13,234			—		76,962
	General and administrative		—			—			15,892			—		15,892
	Depreciation and amortization		—			416			2,785			—		3,201
Total operating expenses			—			294,057			255,466			—		549,523
Operating loss			—			(1,892	)		(2,251	)		—		(4,143	)
	Interest and other income		—			75			428			—		503
	Interest expense		—			—			(1,439	)		—		(1,439	)
	Equity in earnings of subsidiaries		(7,939	)		—			—			7,939		—
(Loss) income from continuing operations before income taxes			(7,939	)		(1,817	)		(3,262	)		7,939		(5,079	)
	Provision for income taxes		—			—			—			—		—
(Loss) income from continuing operations			(7,939	)		(1,817	)		(3,262	)		7,939		(5,079	)
Loss from discontinued operations			—			(803	)		(2,057	)		—		(2,860	)
Net (loss) income		$	(7,939	)	$	(2,620	)	$	(5,319	)	$	7,939	$	(7,939	)

14

Unaudited Condensed Consolidating Balance Sheet
As of December 31, 2005
(amounts in thousands)

	Parent		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			FVE Consolidated
ASSETS
Current assets
Cash	$	—	$	7,226	$	9,503	$	—		$	16,729
Accounts receivable, net		—		15,535		30,589		—			46,124
Prepaid expenses and other current assets		—		9,485		22,542		—			32,027
Total current assets		—		32,246		62,634		—			94,880
Property and equipment, net		—		19,200		77,543		—			96,743
Investment in subsidiary and long term recievable from (to) subsidiaries		200		—		200		(400	)		—
Restricted cash		—		—		12,957		—			12,957
Intercompany		113,749		—		—		(113,749	)		—
Mortgage notes receivable		—		—		5,971		—			5,971
Goodwill		—		—		14,059		—			14,059
Other long term assets		—		402		3,928		—			4,330
Total assets	$	113,949	$	51,848	$	177,292	$	(114,149	)	$	228,940
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable and other current liabilities	$	—	$	32,103	$	57,239	$	—		$	89,342
Current mortgage notes payable		—		—		626		—			626
Total current liabilities		—		32,103		57,865		—			89,968
Long term liabilities:
Mortgage notes payable		—		—		44,703		—			44,703
Notes payable to related parties		200		—		—		(200	)		—
Other long term liabilities		—		7,086		18,379		—			25,465
Total long term liabilities		200		7,086		63,082		(200	)		70,168
Total shareholders' equity		113,749		12,659		56,345		(113,949	)		68,804
Total liabilities and shareholders' equity	$	113,949	$	51,848	$	177,292	$	(114,149	)	$	228,940

15

Unaudited Condensed Consolidating Balance Sheet
As of December 31, 2004
(amounts in thousands)

	Parent		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			FVE Consolidated
ASSETS
Current assets
Cash	$	—	$	8,387	$	22,555	$	—		$	30,942
Accounts receivable, net		—		10,892		25,850		—			36,742
Prepaid expenses and other current assets		—		11,191		16,783		—			27,974
Total current assets		—		30,470		65,188		—			95,658
Property and equipment, net		—		12,085		83,104		—			95,189
Investment in subsidiary and long term recievable from (to) subsidiaries		200		—		200		(400	)		—
Restricted cash		—		—		10,749		—			10,749
Intercompany		56,551		—		—		(56,551	)		—
Mortgage notes receivable		—		—		6,099		—			6,099
Goodwill		—		—		11,548		—			11,548
Other long term assets		—		402		3,340		—			3,742
Total assets	$	56,751	$	42,957	$	180,228	$	(56,951	)	$	222,985
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable and other current liabilities	$	—	$	28,033	$	38,402	$	—		$	66,435
Current mortgage notes payable		—		—		463		—			463
Total current liabilities		—		28,033		38,865		—			66,898
Long term liabilities:
Mortgage notes payable		—		—		42,118		—			42,118
Notes payable to related parties		200		—		—		(200	)		—
Other long term liabilities		—		6,191		11,874		—			18,065
Total long term liabilities		200		6,191		53,992		(200	)		60,183
Total shareholders' equity		56,551		8,733		87,371		(56,751	)		95,904
Total liabilities and shareholders' equity	$	56,751	$	42,957	$	180,228	$	(56,951	)	$	222,985

16

Unaudited Condensed Consolidating Cash Flow Statement
For the year ended December 31, 2005
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
Cash Flows from operating activities:
Net (loss) income		$	(84,159	)	$	(83,382	)	$	(777	)	$	84,159		$	(84,159	)
Undistributed equity in earnings of subsidiaries			84,159			—			—			(84,159	)		—
Adjustments to reconcile net (loss) income to cash provided by (used in) operating activities, net			—			93,244			(65,962	)		—			27,282
	Net cash provided by (used in) operating activities		—			9,862			(66,739	)		—			(56,877	)
Cash Flows from investing activities:
Capital expenditures			—			(20,392	)		(89,962	)		—			(110,354	)
Proceeds from the sale of property and equipment			—			7,769			88,379			—			96,148
Other, net			—			1,600			(4,091	)		—			(2,491	)
	Net cash used in investing activities		—			(11,023	)		(5,674	)		—			(16,697	)
Cash Flows from financing activities:
Proceeds from issuance of common shares, net			—			—			56,613			—			56,613
Change in borrowings, net			—			—			2,748			—			2,748
Other, net			—			—			—			—			—
	Net cash provided by financing activities		—			—			59,361			—			59,361
Change in cash and cash equivalents			—			(1,161	)		(13,052	)		—			(14,213	)
Cash and cash equivalents at beginning of period			—			8,387			22,555			—			30,942
Cash and cash equivalents at end of period		$	—		$	7,226		$	9,503		$	—		$	16,729

17

Unaudited Condensed Consolidating Cash Flow Statement
For the year ended December 31, 2004
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
Cash Flows from operating activities:
Net income (loss)		$	3,291		$	1,201		$	2,090		$	(3,291	)	$	3,291
Undistributed equity in earnings of subsidiaries			(3,291	)		—			—			3,291			—
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities, net			—			(4,276	)		627			—			(3,649	)
	Net cash (used in) provided by operating activities		—			(3,075	)		2,717			—			(358	)
Cash Flows from investing activities:
Capital expenditures			—			(12,269	)		(130,192	)		—			(142,461	)
Proceeds from the sale of property and equipment			—			5,746			126,393			—			132,139
Other, net			—			4,679			(2,901	)		—			1,778
	Net cash used in investing activities		—			(1,844	)		(6,700	)		—			(8,544	)
Cash Flows from financing activities:
Proceeds from issuance of common shares, net			—			—			27,685			—			27,685
Change in borrowings, net			—			—			(5,452	)		—			(5,452	)
Other, net			—			—			—			—			—
	Net cash provided by financing activities		—			—			22,233			—			22,233
Change in cash and cash equivalents			—			(4,919	)		18,250			—			13,331
Cash and cash equivalents at beginning of period			—			13,306			4,305			—			17,611
Cash and cash equivalents at end of period		$	—		$	8,387		$	22,555		$	—		$	30,942

18

Unaudited Condensed Consolidating Cash Flow Statement
For the year ended December 31, 2003
(amounts in thousands)

		Parent			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			FVE Consolidated
Cash Flows from operating activities:
Net (loss) income		$	(7,939	)	$	(2,620	)	$	(5,319	)	$	7,939		$	(7,939	)
Undistributed equity in earnings of subsidiaries			7,939			—			—			(7,939	)		—
Adjustments to reconcile net (loss) income to cash provided by (used in) operating activities, net			—			23,843			3,008			—			26,851
	Net cash provided by (used in) operating activities		—			21,223			(2,311	)		—			18,912
Cash Flows from investing activities:
Capital expenditures			—			(7,753	)		(11,134	)		—			(18,887	)
Proceeds from the sale of property and equipment			—			2,750			24,335			—			27,085
Other, net			—			(5,568	)		(8,514	)		—			(14,082	)
	Net cash (used in) provided by investing activities		—			(10,571	)		4,687			—			(5,884	)
Cash Flows from financing activities:
Proceeds from issuance of common shares, net			—			—			—			—			—
Change in borrowings, net			—			—			(5,687	)		—			(5,687	)
Other, net			—			—			—			—			—
	Net cash used in financing activities		—			—			(5,687	)		—			(5,687	)
Change in cash and cash equivalents			—			10,652			(3,311	)		—			7,341
Cash and cash equivalents at beginning of period			—			2,654			7,616			—			10,270
Cash and cash equivalents at end of period		$	—		$	13,306		$	4,305		$	—		$	17,611

19

Five Star Quality Care, Inc.

UNAUDITED PRO FORMA FINANCIAL INFORMATION
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
As of June 30, 2006
(dollars in thousands)

	Historical		Adjustments for convertible senior notes offering			Adjusted for convertible senior notes offering
ASSETS
Current assets
Cash and cash equivalents	$	23,576	$	77,550	(A)	$	101,126
Accounts receivable, net		46,340		—			46,340
Prepaid expenses and other current assets		41,890		—			41,890
Total current assets		111,806		77,550			189,356
Property and equipment, net		102,050		—			102,050
Restricted cash		13,697		—			13,697
Mortgage notes receivable		3,725		—			3,725
Goodwill		16,901		—			16,901
Other long term assets		4,155		2,450	(B)		6,605
Total assets	$	252,334	$	80,000		$	332,334
LIABILITIES AND SHAREHOLDERS' EQUITY
Total current liabilities	$	83,889	$	—		$	83,889
Mortgage notes payable		44,423		—			44,423
% Convertible Senior Notes due 2026		—		80,000	(C)		80,000
Other long term liabilities		27,049		—			27,049
Total liabilities		155,361		80,000			235,361
Total shareholders' equity		96,973		—			96,973
Total liabilities and shareholders' equity	$	252,334	$	80,000		$	332,334

20

Five Star Quality Care, Inc.

UNAUDITED PRO FORMA CONSOLIDATED INCOME STATEMENT
For the six months ended June 30, 2006
(dollars in thousands)

		Historical			Adjustments for April 2006 equity offering			Adjusted for April 2006 equity offering			Adjustments for 2006 Sunrise termination			Adjusted for April 2006 equity offering and 2006 Sunrise termination			Adjustments for convertible senior note offering			Adjusted for April 2006 equity offering, 2006 Sunrise termination and convertible senior note offering
REVENUES:
	Net revenues from residents	$	365,398		$	—		$	365,398		$	—		$	365,398		$	—		$	365,398
	Pharmacy revenue		24,410			—			24,410			—			24,410			—			24,410
Total revenues			389,808			—			389,808			—			389,808			—			389,808
OPERATING EXPENSES:
	Property level operating expenses		281,381			—			281,381			—			281,381			—			281,381
	Termination payment to SLS		89,833			—			89,833			—			89,833			—			89,833
	Pharmacy expenses		23,189			—			23,189			—			23,189			—			23,189
	Management fee to SLS		6,392			—			6,392			(3,333	)(E)		3,059			—			3,059
	Rent expense		52,563			—			52,563			—			52,563			—			52,563
	General and administrative		14,635			—			14,635			—			14,635			—			14,635
	Depreciation and amortization		4,561			—			4,561			—			4,561			—			4,561
Total operating expenses			472,554			—			472,554			(3,333	)		469,221			—			469,221
Operating (loss) income			(82,746	)		—			(82,746	)		3,333			(79,413	)		—			(79,413	)
	Interest and other income		1,140			—			1,140			—			1,140			—			1,140
	Interest expense		(1,633	)		—			(1,633	)		—			(1,633	)		(1,661	)(F)		(3,294	)
(Loss) income from continuing operations before income taxes			(83,239	)		—			(83,239	)		3,333			(79,906	)		(1,661	)		(81,567	)
	Provision for income taxes		—			—			—			—			—			—			—
(Loss) income from continuing operations		$	(83,239	)	$	—		$	(83,239	)	$	3,333		$	(79,906	)	$	(1,661	)	$	(81,567	)
Weighted Average Shares Outstanding:
	Basic		25,551			6,030	(D)		31,581			—			31,581			—			31,581
	Fully Diluted		25,551			6,030			31,581			—			31,581			—			31,581
Basic and diluted loss per share from:
	Basic	$	(3.26	)				$	(2.64	)				$	(2.53	)				$	(2.58	)
	Fully Diluted	$	(3.26	)				$	(2.64	)				$	(2.53	)				$	(2.58	)

21

Five Star Quality Care, Inc.

NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

(amounts in thousands, except share and per share amounts)

INTRODUCTION TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

        The unaudited pro forma consolidated balance sheet as of June 30, 2006, presents the consolidated financial position of Five Star as if our October 2006 private placement of our convertible senior notes had been completed as of June 30, 2006, as described in the notes thereto. The unaudited pro forma consolidated statement of operations for the six months ended June 30, 2006, presents the consolidated results of operations of Five Star as if (1) our April 2006 equity offering; (2) the reduction in our management fees payable in respect of 10 SLS management agreements that we terminated in June 2006; and (3) our October 2006 private placement of our convertible senior notes (assuming the initial purchasers' over-allotment option is not exercised and not giving effect to the conversion of the notes), had been completed as of January 1, 2006, as described in the notes thereto.

        These unaudited pro forma consolidated financial statements do not represent our consolidated financial condition or results of operations for any future date or period. Actual future results may be materially different from pro forma results. Differences could arise from many factors, including, but not limited to, those set forth under "Warning concerning forward looking statements." These unaudited pro forma consolidated financial statements should be read in conjunction with our historical financial statements incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2005 and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2006 and June 30, 2006 and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" contained therein. These unaudited pro forma consolidated financial statements do not give pro forma effect to certain transactions, including, without limitation, the eight senior living communities we began to operate in September and October 2006 and the two rehabilitation hospitals we began to operate in October 2006.

Pro forma consolidated balance sheet as of June 30, 2006 adjustments

A.

Represents the proceeds we received from our October 2006 private placement of our convertible senior notes as follows:

Convertible senior notes issued	$	80,000
Initial purchasers discount and commissions and other offering costs, estimated		2,450
Net proceeds	$	77,550

B.

Represents deferred finance costs we expect to incur as a result of our October 2006 private placement of our convertible senior notes. Amounts represent estimated initial purchasers discount and commissions and other offering costs which will be amortized over the expected term of the convertible senior notes.

C.

Represents the principal amount of the convertible senior notes.

Pro forma consolidated statement of operations for the six months ended June 30, 2006 adjustments

D.

Represents our issuance of common shares in our April 2006 equity offering. The adjustment has been weighted to reflect shares actually outstanding as of June 30, 2006.

22

E.

Represents the elimination of the contractual management fee with SLS. In connection with the termination of 10 management agreements with SLS, we will no longer be required to make these payments.

F.

Represents the interest expense we will incur on the convertible senior notes, as well as amortization of deferred finance fees. The adjustment is calculated as follows:

Interest expense for six months on the $80,000 of convertible senior notes at an assumed rate of 4.0% per annum		(1,600	)
Amortization of deferred finance fees (see Note B) for six months. Deferred finance costs amortized over expected term of the convertible senior notes, or 20 years		(61	)
Total adjustment	$	(1,661	)

23

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	FIVE STAR QUALITY CARE, INC.
	BY:	/S/  BRUCE J. MACKEY JR. Name: Bruce J. Mackey Jr. Title: Treasurer and Chief Financial Officer
Date: November 22, 2006

24

QuickLinks

Five Star Quality Care, Inc. UNAUDITED PRO FORMA FINANCIAL INFORMATION UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET As of June 30, 2006 (dollars in thousands)
Five Star Quality Care, Inc. UNAUDITED PRO FORMA CONSOLIDATED INCOME STATEMENT For the six months ended June 30, 2006 (dollars in thousands)
SIGNATURES